Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Omeprazole 20 mg Capsules vs Losec 20 mg in Healthy Subjects
NCT05849883Completed
- Sponsor
- Kalbe Farma
- Start
- Dec 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of omeprazole in gastroesophageal reflux disease (GERD) and Peptic ulcer disease (PUD) (2 arms), sponsored by Kalbe Farma. Primary endpoints: Geometric Mean Ratio of Cmax and Geometric Mean Ratio of AUCt. Started Dec 2020; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT05849883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05849883.